Trials / Conditions / HER2-low Expressing Breast Cancer
HER2-low Expressing Breast Cancer
4 registered clinical trials studyying HER2-low Expressing Breast Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis NCT07150208 | Fudan University | Phase 2 |
| Completed | HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada NCT06386263 | AstraZeneca | — |
| Recruiting | DESTINY Breast Respond HER2-low Europe NCT05945732 | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | — |
| Active Not Recruiting | Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive E NCT05165225 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 |